Cerebral Hemodynamic Responses to Disease-Modifying and Curative Sickle Cell Disease Therapies
Findings demonstrate improvement in cerebral hemodynamics after transfusion and transplant therapies compared with hydroxyurea therapy; quantitative relationships should provide a framework for using these measures as trial end points to assess how new SCD therapies affect brain health.
Authors
- Wesley Richerson (ORCID: https://orcid.org/0000-0001-8194-9434)
- Megan Aumann (ORCID: https://orcid.org/0000-0002-3924-8455)
- Alexander K. Song (ORCID: https://orcid.org/0000-0003-1590-4144)
- Michael R. DeBaun (ORCID: https://orcid.org/0000-0002-0574-1604)
- Adetola A. Kassim (ORCID: https://orcid.org/0000-0002-0484-5903)
- Manus J. Donahue (ORCID: https://orcid.org/0000-0002-4123-9275)
- Lori C. Jordan (ORCID: https://orcid.org/0000-0001-7240-0415)
- L. Taylor Davis (ORCID: https://orcid.org/0000-0003-2939-3875)
- Samantha Davis
- Dann Martin (ORCID: https://orcid.org/0000-0003-1906-2538)
- Lauren C. Milner
Institutions
- Neurology, Inc (US)
Publication Details
- Journal
- Neurology
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1212/wnl.0000000000210191
- Citations
- 1
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.44